Spears Abacus Advisors LLC Bristol Myers Squibb CO Transaction History
Spears Abacus Advisors LLC
- $4.12 Billion
- Q1 2025
A detailed history of Spears Abacus Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 271,869 shares of BMY stock, worth $12.3 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
271,869
Previous 271,527
0.13%
Holding current value
$12.3 Million
Previous $15.4 Million
7.97%
% of portfolio
0.4%
Previous 0.35%
Shares
21 transactions
Others Institutions Holding BMY
# of Institutions
2,691Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.68 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.2 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.9 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.3 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.01 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...